The Market Doesn't Like What It Sees From Omda AS' (OB:OMDA) Revenues Yet
Dec 21
Have your own idea? Try our Stock Screener
Norwegian (OSEAX) Healthcare Sector Analysis
UpdatedDec 30, 2024
DataAggregated Company Financials
Companies25
- 7D0.1%
- 3M-6.6%
- 1Y-39.2%
- YTD-46.8%
The Healthcare is pretty flat in the last 7 days, but Hofseth BioCare has stood out, gaining 12%. Unfortunately though, the industry is down 39% over the past 12 months. As for the next few years, earnings are expected to grow by 47% per annum.
Sector Valuation and Performance
Has the Norwegian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 31 Dec 2024 | NOK 16.1b | NOK 3.8b | -NOK 1,107,375,521.02 | 25.6x | -14.5x | 4.3x |
| Thu, 28 Nov 2024 | NOK 16.8b | NOK 4.0b | -NOK 980,409,107.84 | 22.2x | -17.1x | 4.2x |
| Sat, 26 Oct 2024 | NOK 17.7b | NOK 4.0b | -NOK 977,593,307.64 | 19.8x | -18.1x | 4.4x |
| Mon, 23 Sep 2024 | NOK 18.7b | NOK 4.0b | -NOK 952,381,210.41 | 20x | -19.6x | 4.7x |
| Wed, 21 Aug 2024 | NOK 20.5b | NOK 4.0b | -NOK 914,525,499.53 | 19.5x | -22.4x | 5.1x |
| Fri, 19 Jul 2024 | NOK 22.0b | NOK 4.0b | -NOK 974,400,429.87 | 16.7x | -22.5x | 5.5x |
| Sun, 16 Jun 2024 | NOK 22.6b | NOK 4.1b | -NOK 949,643,369.78 | 15.6x | -23.8x | 5.5x |
| Tue, 14 May 2024 | NOK 21.8b | NOK 4.2b | -NOK 1,130,758,107.58 | 17.8x | -19.3x | 5.2x |
| Thu, 11 Apr 2024 | NOK 22.1b | NOK 4.2b | -NOK 1,117,820,690.95 | 28.9x | -19.8x | 5.3x |
| Sat, 09 Mar 2024 | NOK 21.6b | NOK 4.2b | -NOK 1,093,680,878.56 | 27.7x | -19.8x | 5.2x |
| Mon, 05 Feb 2024 | NOK 29.0b | NOK 4.1b | -NOK 1,594,025,589.00 | 23.3x | -18.2x | 7.1x |
| Wed, 03 Jan 2024 | NOK 30.2b | NOK 4.1b | -NOK 1,582,203,882.00 | 22.5x | -19.1x | 7.4x |
| Fri, 01 Dec 2023 | NOK 27.4b | NOK 4.1b | -NOK 1,590,980,713.00 | 22.3x | -17.2x | 6.7x |
| Sun, 29 Oct 2023 | NOK 25.3b | NOK 3.5b | -NOK 1,864,377,320.00 | 29.9x | -13.6x | 7.3x |
| Tue, 26 Sep 2023 | NOK 28.2b | NOK 3.5b | -NOK 1,818,280,092.00 | 33.5x | -15.5x | 7.9x |
| Thu, 24 Aug 2023 | NOK 27.9b | NOK 3.5b | -NOK 1,818,921,945.00 | 32.6x | -15.3x | 7.9x |
| Sat, 22 Jul 2023 | NOK 29.8b | NOK 3.4b | -NOK 1,815,462,664.00 | 30.1x | -16.4x | 8.8x |
| Mon, 19 Jun 2023 | NOK 30.5b | NOK 3.4b | -NOK 1,818,595,681.00 | 42.5x | -16.8x | 9.1x |
| Wed, 17 May 2023 | NOK 29.9b | NOK 3.4b | -NOK 1,791,070,762.00 | 45.4x | -16.7x | 8.8x |
| Fri, 14 Apr 2023 | NOK 30.2b | NOK 3.1b | -NOK 1,856,682,158.00 | 31.5x | -16.3x | 9.7x |
| Sun, 12 Mar 2023 | NOK 29.9b | NOK 3.1b | -NOK 1,876,994,486.00 | 31.7x | -15.9x | 9.6x |
| Tue, 07 Feb 2023 | NOK 34.3b | NOK 3.6b | -NOK 1,862,032,067.00 | 34.9x | -18.4x | 9.5x |
| Thu, 05 Jan 2023 | NOK 34.5b | NOK 3.6b | -NOK 1,838,339,222.00 | 35.9x | -18.8x | 9.6x |
| Sat, 03 Dec 2022 | NOK 33.9b | NOK 3.6b | -NOK 1,823,200,720.00 | 38.5x | -18.6x | 9.5x |
| Mon, 31 Oct 2022 | NOK 31.8b | NOK 3.5b | -NOK 1,752,907,908.00 | 39.2x | -18.1x | 9.1x |
| Wed, 28 Sep 2022 | NOK 30.6b | NOK 3.5b | -NOK 1,777,760,980.00 | 55.9x | -17.2x | 8.8x |
| Fri, 26 Aug 2022 | NOK 36.7b | NOK 3.3b | -NOK 1,697,453,002.00 | 62.2x | -21.6x | 11x |
| Sun, 24 Jul 2022 | NOK 37.4b | NOK 3.3b | -NOK 1,742,802,380.00 | 83.9x | -21.5x | 11.4x |
| Tue, 21 Jun 2022 | NOK 37.2b | NOK 3.6b | -NOK 1,357,511,050.00 | 56.7x | -27.4x | 10.2x |
| Thu, 19 May 2022 | NOK 36.8b | NOK 3.6b | -NOK 1,244,402,887.00 | 48.7x | -29.6x | 10.4x |
| Sat, 16 Apr 2022 | NOK 42.9b | NOK 3.4b | -NOK 1,202,334,885.00 | 44.1x | -35.7x | 12.5x |
| Mon, 14 Mar 2022 | NOK 41.6b | NOK 5.1b | NOK 208.6m | 39.9x | 199.7x | 8.1x |
| Wed, 09 Feb 2022 | NOK 49.0b | NOK 4.9b | NOK 285.1m | 44.9x | 171.9x | 9.9x |
| Fri, 07 Jan 2022 | NOK 63.5b | NOK 4.5b | -NOK 108,479,541.00 | n/a | -585.1x | 14.2x |
Price to Earnings Ratio
-585.1x
Current Industry PE
- Investors are pessimistic on the Norwegian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.1x is higher than the industry's current PS ratio of 4.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have deteriorated over the last three years.
- Revenues have also declined 5.5% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Norwegian Healthcare sector?
| NO Market | 1.37% | |
| Healthcare | 0.15% | |
| Pharma | 0.51% | |
| Biotech | 0.31% | |
| Healthtech | 0.24% | |
| Healthcare Services | 0% | |
| Life Sciences | 0% | |
| Medical Equipment | -0.45% | |
Industry PE
- Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 25.3x.
- Analysts are expecting annual earnings growth of 81.3%, which is higher than its past year's earnings growth of 0.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 81% over the next 5 years.
- This is better than its past earnings growth rate of 0.7% per year.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NORDH Nordhealth | NOK 44.40 | 11.6% +NOK 363.7m | 79.0% | PS6.8x | |
| HBC Hofseth BioCare | NOK 1.70 | 6.3% +NOK 41.1m | -35.1% | PS2.8x | |
| OMDA Omda | NOK 33.00 | 5.8% +NOK 36.3m | -10.8% | PS1.6x | |
| ONCIN Oncoinvent | NOK 3.39 | 13.0% +NOK 36.0m | n/a | n/a | |
| NYKD Nykode Therapeutics | NOK 3.05 | 0.9% +NOK 8.5m | -85.8% | PS20x |
